Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5772750

CN(CCCNC(=O)CCc1cnoc1-c1ccc(C(F)(F)F)cc1)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
FAAH O00519 1/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
ALOX15 P16050 1/20 0.40
HTT P42858 1/20 0.40
ACKR3 P25106 1/20 0.40
CNR1 P21554 1/20 0.40
TRPV1 Q8NER1 3/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 2/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MCHR1 Q99705 1/20 0.37
GAA P10253 2/20 0.36
CASR P41180 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5774082 0.92 ACKR3 (0.42) MAPTALDH1A1LMNAALOX15HTT
Trifluoroacetic Acid SCHEMBL5776657 0.87 MAPT (0.42) MAPTTRPV1HPGDTSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL5774050 0.86 TRPV1 (0.43) MAPTFAAHALDH1A1LMNAALOX15
Trifluoroacetic Acid SCHEMBL5775554 0.83 HDAC4 (0.43) MAPTFAAHALDH1A1TRPV1TSHR
SCHEMBL5907124 0.82 FAAH (0.36) FAAHCNR1TRPV1
Trifluoroacetic Acid SCHEMBL5776374 0.81 MAPT (0.53) MAPTALDH1A1LMNAALOX15HTT
Trifluoroacetic Acid SCHEMBL5775717 0.79 GSK3B (0.44) FAAHTRPV1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL5774893 0.79 GAA (0.47) MAPTALDH1A1LMNAALOX15HTT
Trifluoroacetic Acid SCHEMBL5771103 0.79 HDAC4 (0.36) MAPTALDH1A1LMNATRPV1HPGD
Trifluoroacetic Acid SCHEMBL5772663 0.79 IDE (0.49) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MAPT 4701/4885FAAH 2848/4885ALDH1A1 1045/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MAPT 4763/4885FAAH 1727/4885ALDH1A1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.